Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| RNA (Atrium Therapeutics, Inc. Common Stock) | -82.52% | -57.68% | 1.33% | -13.53% | NA | NA | NA | … | … |
Data as of 06/16/2026, Common starting date is 06/15/2020
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| RNA (Atrium Therapeutics, Inc. Common Stock) | 06/15/2020 | 06/16/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 7.23 | -57.68 | 1.33 | -13.53 | NA | NA | NA | … | … | -82.52 | 148.04 | 232.71 | -59.22 | -6.65 | -6.86 | -11.70 |
| Sharpe Ratio | NA | -0.37 | -0.01 | -0.16 | NA | NA | NA | … | … | -0.41 | 2.04 | 3.12 | -0.89 | -0.09 | -0.09 | -0.32 |
| Standard Deviation(%) | NA | 171.32 | 114.85 | 103.32 | NA | NA | NA | … | … | 242.63 | 72.96 | 73.46 | 71.55 | 89.50 | 74.82 | 64.17 |
| Draw Down(%) | NA | 84.16 | 84.16 | 84.16 | NA | NA | NA | … | … | 84.16 | 31.42 | 42.65 | 81.01 | 57.70 | 37.94 | 31.19 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/16/2026, Common starting date is 06/15/2020
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| RNA (Atrium Therapeutics, Inc. Common Stock) |
-40.73%
Oct 2020 – Oct 2023 |
-11.44%
Apr 2021 – Apr 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| RNA (Atrium Therapeutics, Inc. Common Stock) |
83.31%
Nov 2022 – Nov 2025 |
25.97%
Jan 2021 – Jan 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart